Viatris Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VIATRIS, and what generic and branded alternatives to VIATRIS drugs are available?
VIATRIS has seventeen approved drugs.
Drugs and US Patents for Viatris
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Viatris | REVATIO | sildenafil citrate | TABLET;ORAL | 021845-001 | Jun 3, 2005 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Viatris | ZOLOFT | sertraline hydrochloride | CONCENTRATE;ORAL | 020990-001 | Dec 7, 1999 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Viatris | NEURONTIN | gabapentin | CAPSULE;ORAL | 020235-003 | Dec 30, 1993 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-003 | Nov 2, 1990 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Viatris | NEURONTIN | gabapentin | CAPSULE;ORAL | 020235-002 | Dec 30, 1993 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Viatris | REVATIO | sildenafil citrate | FOR SUSPENSION;ORAL | 203109-001 | Aug 30, 2012 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Viatris | NORVASC | amlodipine besylate | TABLET;ORAL | 019787-001 | Jul 31, 1992 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Viatris
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viatris | ZOLOFT | sertraline hydrochloride | CONCENTRATE;ORAL | 020990-001 | Dec 7, 1999 | 5,744,501 | ⤷ Try a Trial |
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | 6,232,304 | ⤷ Try a Trial |
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-002 | Feb 5, 2001 | 6,245,766 | ⤷ Try a Trial |
Viatris | NEURONTIN | gabapentin | CAPSULE;ORAL | 020235-002 | Dec 30, 1993 | 5,084,479*PED | ⤷ Try a Trial |
Viatris | ZOLOFT | sertraline hydrochloride | CONCENTRATE;ORAL | 020990-001 | Dec 7, 1999 | 6,727,283*PED | ⤷ Try a Trial |
Viatris | ZOLOFT | sertraline hydrochloride | TABLET;ORAL | 019839-003 | Dec 30, 1991 | 5,789,449 | ⤷ Try a Trial |
Viatris | NEURONTIN | gabapentin | TABLET;ORAL | 020882-002 | Oct 9, 1998 | 5,084,479*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VIATRIS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 150 mg and 200 mg | ➤ Subscribe | 2005-11-09 |
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2004-10-25 |
➤ Subscribe | Sublingual Tablets | 0.6 mg | ➤ Subscribe | 2011-12-29 |
➤ Subscribe | Capsules | 20 mg, 40 mg, 60 mg and 80 mg | ➤ Subscribe | 2005-02-07 |
➤ Subscribe | Tablets | 25 mg and 50 mg | ➤ Subscribe | 2004-11-19 |
➤ Subscribe | Sublingual Tablets | 0.3 mg, 0.4 mg and 0.6 mg | ➤ Subscribe | 2005-10-19 |
Similar Applicant Names
Here is a list of applicants with similar names.